Navigation Links
Riordan Lewis & Haden | Equity Partners Acquires Nutritional Therapy Provider DCRX Infusion
Date:8/3/2012

LOS ANGELES, Aug. 3, 2012 /PRNewswire/ -- Riordan Lewis & Haden | Equity Partners (RLH) is pleased to announce its acquisition of DCRX Infusion, a leading provider of customized nutritional therapy to patients with end stage renal disease.  DCRX, based in Sunrise, Florida, provides products and services to dialysis centers on a nationwide basis.

RLH is privileged to partner in this investment with Robert Funari, an experienced healthcare executive with a successful background in building specialty pharmaceutical companies. Prior to partnering with RLH, Bob was CEO of Crescent Healthcare and of Syncor International. 

According to Michel Glouchevitch, a partner at Riordan Lewis & Haden, "In today's rapidly changing healthcare environment, DCRX is well positioned to continue to achieve significant growth because the Company provides cost-effective clinical care and outstanding service.  With the benefit of Bob Funari's leadership and expertise, DCRX will accelerate its success and improve the quality of life for more dialysis patients."

Robert Funari, CEO of DCRX Infusion added, "I look forward to working with the excellent DCRX team.  Their passion to help dialysis patients, combined with the strategic insight that RLH brings from its 30 year history of helping build high performance service enterprises, are the building blocks which excite me about this outstanding growth opportunity."

DCRX assists dialysis patients who are at higher risk of adverse clinical outcomes because of chronic malnutrition.  The Company's skilled clinicians work with referring nephrologists to formulate and deliver the appropriate parenteral nutrition therapy for each patient.  DCRX also provides a team of pharmacists, nurses, and dieticians that offer comprehensive clinical consulting support for dialysis centers and their patients.  Through this combination of customization and responsive service, the Company has achieved exceptional growth.

Skyline Global Partners, a Chicago-based private equity firm, also participated in the DCRX Infusion investment.

About RLH

Riordan, Lewis & Haden is a leading private equity firm based in Southern California which invests in high growth, lower middle market, enterprises. Focused on business services, healthcare, and government services, RLH has a demonstrated track record of consistent success over the past 30 years. RLH provides capital and assists portfolio company management teams as they navigate the opportunities and challenges of rapid growth. The firm currently manages over $600 million of assets and is actively seeking new portfolio companies.

Contact:
For more information please contact:

Michel Glouchevitch
Partner
Riordan Lewis & Haden | Equity Partners

310-405-7203
mg@rlhequity.com

Visit us online:

www.rlhequity.com

 

 


'/>"/>
SOURCE Riordan Lewis & Haden | Equity Partners
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Law Office of Brodsky & Smith, LLC Announces Settlements of Yaz, and Yasmin Cases
2. Frost & Sullivan: Improving Economies in Indonesia and Vietnam Present Strong Growth Potential in Healthcare
3. Austin Recovery Becomes Learning Environment for Texas A&M Health Science Center Medical Students
4. Center for Medicare & Medicaid Innovation Awards $19 Million Grant to Develop Oncology Medical Home Model
5. Vaginal Mesh Lawsuits Pick Up Momentum, According To Pulaski & Middleman, LLC
6. Lippincott Williams & Wilkins Launches Electronic Health Record (EHR) Learning Tool to Help Future Nurses Prepare for New Practice Requirements
7. Verenium To Present At The Jefferies 2012 Global Industrial And Aerospace & Defense Conference
8. United Seating & Mobility Completes Acquisition of Active American Mobilitys Rehab Division
9. United Seating & Mobility Completes Acquisition of Active American Mobility
10. Ablation Devices Market to 2016 - (Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Cardiac, Cancer and Gynecology) - Global Market Forecast and Trends Analysis by Technology, Devices & Applications
11. Lower Operating Expense Augments Digital X-rays Uptake Across Industries, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets has announced ... 2016" report to their offering. ... The IPF pipeline is very strong with a total of ... Co., Inc., Biogen and Sanofi are involved in the development of the ... one is in Phase III stage, 15 are in Phase II stage, ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... their offering. ... provides separate comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America , and Rest of ... 2022. Also, a six-year historic analysis is provided for these markets. Market ...
(Date:3/24/2017)... March 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... Commitment Term Sheet (the "Definitive Financing") it entered ... the Company,s stockholders, who are referred to in ... Form 8-K filed with the Securities and Exchange ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... The iaedp Foundation, the premier ... professionals caring for those suffering from the full spectrum of disordered eating, announced today ... disorders professionals from nearly all 50 states and several countries converged on the Green ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... its innovative EcoQube Frame vertical micro-veggies garden on Kickstarter . Surpassing the ... product – with nearly 2,000 consumers (and counting) already backing the campaign. ...
(Date:3/24/2017)... Oakland, CA (PRWEB) , ... March 24, 2017 ... ... present on two panels at the Advanced ERISA Benefit Claims Litigation seminar in ... and Creating the Administrative Record, The majority of cases litigated under ERISA involve ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ... prep patients for colonoscopy at the HyGIeaCare® Center that is to be located ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... to Walk with God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward ... Learning How to Walk with God #TruthwithGrace” is the creation of published author ...
Breaking Medicine News(10 mins):